QIAGEN's (QGEN) next-generation sequencing test aims to aid personalized medicine research in solid tumor types, including ovarian cancer, and improve decentralized testing capabilities.
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock?
QIAGEN's (QGEN) solid potential in the NGS platform buoys optimism for investors.